• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于参考的生存时间数据敏感性分析。

Reference-based sensitivity analysis for time-to-event data.

作者信息

Atkinson Andrew, Kenward Michael G, Clayton Tim, Carpenter James R

机构信息

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

出版信息

Pharm Stat. 2019 Nov;18(6):645-658. doi: 10.1002/pst.1954. Epub 2019 Jul 15.

DOI:10.1002/pst.1954
PMID:31309730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6899641/
Abstract

The analysis of time-to-event data typically makes the censoring at random assumption, ie, that-conditional on covariates in the model-the distribution of event times is the same, whether they are observed or unobserved (ie, right censored). When patients who remain in follow-up stay on their assigned treatment, then analysis under this assumption broadly addresses the de jure, or "while on treatment strategy" estimand. In such cases, we may well wish to explore the robustness of our inference to more pragmatic, de facto or "treatment policy strategy," assumptions about the behaviour of patients post-censoring. This is particularly the case when censoring occurs because patients change, or revert, to the usual (ie, reference) standard of care. Recent work has shown how such questions can be addressed for trials with continuous outcome data and longitudinal follow-up, using reference-based multiple imputation. For example, patients in the active arm may have their missing data imputed assuming they reverted to the control (ie, reference) intervention on withdrawal. Reference-based imputation has two advantages: (a) it avoids the user specifying numerous parameters describing the distribution of patients' postwithdrawal data and (b) it is, to a good approximation, information anchored, so that the proportion of information lost due to missing data under the primary analysis is held constant across the sensitivity analyses. In this article, we build on recent work in the survival context, proposing a class of reference-based assumptions appropriate for time-to-event data. We report a simulation study exploring the extent to which the multiple imputation estimator (using Rubin's variance formula) is information anchored in this setting and then illustrate the approach by reanalysing data from a randomized trial, which compared medical therapy with angioplasty for patients presenting with angina.

摘要

对事件发生时间数据的分析通常基于随机删失假设,即,在模型中的协变量条件下,无论事件时间是被观察到还是未被观察到(即右删失),其分布都是相同的。当仍在随访中的患者继续接受其分配的治疗时,在这个假设下进行的分析大致针对的是法律上的,或“治疗期间策略”的估计量。在这种情况下,我们很可能希望探究我们的推断对于删失后患者行为的更务实、实际的或“治疗策略”假设的稳健性。当删失发生是因为患者改变或恢复到常规(即参照)护理标准时,情况尤其如此。最近的研究表明,对于具有连续结局数据和纵向随访的试验,如何使用基于参照的多重填补来解决此类问题。例如,试验组中的患者在退出试验后假设恢复到对照组(即参照)干预,从而对其缺失数据进行填补。基于参照的填补有两个优点:(a)它避免了用户指定大量描述患者退出后数据分布的参数;(b)在很好的近似程度上,它以信息为锚定,因此在敏感性分析中,主要分析下由于缺失数据而损失的信息比例保持不变。在本文中,我们以生存背景下的最新研究为基础,提出一类适用于事件发生时间数据的基于参照的假设。我们报告了一项模拟研究,探究多重填补估计量(使用鲁宾方差公式)在这种情况下以信息为锚定的程度,然后通过重新分析一项随机试验的数据来说明该方法,该试验比较了药物治疗与血管成形术对心绞痛患者的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/d0fdbef6a467/PST-18-645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/405329915b3c/PST-18-645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/7b0ccf6110e7/PST-18-645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/5f525eaaeeb6/PST-18-645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/80f670447eb1/PST-18-645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/d0fdbef6a467/PST-18-645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/405329915b3c/PST-18-645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/7b0ccf6110e7/PST-18-645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/5f525eaaeeb6/PST-18-645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/80f670447eb1/PST-18-645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e0/6899641/d0fdbef6a467/PST-18-645-g005.jpg

相似文献

1
Reference-based sensitivity analysis for time-to-event data.基于参考的生存时间数据敏感性分析。
Pharm Stat. 2019 Nov;18(6):645-658. doi: 10.1002/pst.1954. Epub 2019 Jul 15.
2
Missing data sensitivity analysis for recurrent event data using controlled imputation.使用对照插补法对复发事件数据进行缺失数据敏感性分析。
Pharm Stat. 2014 Jul-Aug;13(4):258-64. doi: 10.1002/pst.1624. Epub 2014 Jun 16.
3
Reference-Based Multiple Imputation for Longitudinal Binary Data.纵向二元数据的基于参考的多重填补
Stat Med. 2025 Feb 10;44(3-4):e10301. doi: 10.1002/sim.10301.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Distributional imputation for the analysis of censored recurrent events.分布插补在删失重复事件分析中的应用。
Stat Med. 2024 Jun 15;43(13):2622-2640. doi: 10.1002/sim.10087. Epub 2024 Apr 29.
6
A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome.一种基于因果建模的方法,用于临床试验中具有定量结局的参考赋值和临界点分析。
J Biopharm Stat. 2020 Mar;30(2):334-350. doi: 10.1080/10543406.2019.1684308. Epub 2019 Nov 12.
7
Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.通过评估信息性删失对 PRECISION 中主要估计量的影响来增强临床试验结果的可解释性。
Clin Trials. 2020 Oct;17(5):535-544. doi: 10.1177/1740774520934747. Epub 2020 Jul 9.
8
Control-based imputation for sensitivity analyses in informative censoring for recurrent event data.用于复发事件数据信息删失中敏感性分析的基于对照的插补法。
Pharm Stat. 2017 Nov;16(6):424-432. doi: 10.1002/pst.1821. Epub 2017 Aug 22.
9
Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide.使用对照多重填补法对具有缺失连续结局数据的临床试验进行敏感性分析:实用指南。
Stat Med. 2020 Sep 20;39(21):2815-2842. doi: 10.1002/sim.8569. Epub 2020 May 17.
10
On the multiple imputation variance estimator for control-based and delta-adjusted pattern mixture models.关于基于控制和增量调整模式混合模型的多重填补方差估计器
Biometrics. 2017 Dec;73(4):1379-1387. doi: 10.1111/biom.12702. Epub 2017 Apr 13.

引用本文的文献

1
Application of the estimand framework for an emulated trial using reference based multiple imputation to investigate informative censoring.应用估计量框架,通过基于参考的多重插补模拟试验,研究信息性删失。
BMC Med Res Methodol. 2024 Oct 18;24(1):245. doi: 10.1186/s12874-024-02364-6.
2
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts.利用追回的脱落数据对事件时间终点缺失数据进行插补。
Ther Innov Regul Sci. 2024 Jan;58(1):114-126. doi: 10.1007/s43441-023-00575-5. Epub 2023 Oct 7.
3
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.

本文引用的文献

1
Information-anchored sensitivity analysis: theory and application.信息锚定敏感性分析:理论与应用
J R Stat Soc Ser A Stat Soc. 2019 Feb;182(2):623-645. doi: 10.1111/rssa.12423. Epub 2018 Nov 16.
2
Multiple imputation in Cox regression when there are time-varying effects of covariates.在协变量的时变效应存在时,Cox 回归中的多重插补。
Stat Med. 2018 Nov 10;37(25):3661-3678. doi: 10.1002/sim.7842. Epub 2018 Jul 16.
3
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.
使用估计量框架处理非劣效性试验中的并发事件和缺失数据:一个结核病案例研究。
Clin Trials. 2023 Oct;20(5):497-506. doi: 10.1177/17407745231176773. Epub 2023 Jun 5.
4
SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale.SMIM:使用多重插补和鞅方法的生存敏感性分析的统一框架。
Biometrics. 2023 Mar;79(1):230-240. doi: 10.1111/biom.13555. Epub 2021 Sep 20.
5
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.镥 177-PSMA-617 治疗转移性去势抵抗性前列腺癌。
N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23.
6
A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data.缺失结局数据的随机对照试验中使用控制多重填补的综述。
BMC Med Res Methodol. 2021 Apr 15;21(1):72. doi: 10.1186/s12874-021-01261-6.
7
Missing data: A statistical framework for practice.缺失数据:一种实践的统计框架。
Biom J. 2021 Jun;63(5):915-947. doi: 10.1002/bimj.202000196. Epub 2021 Feb 24.
8
A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic.应对受大流行病影响的随机试验中缺失结局数据的四步策略。
BMC Med Res Methodol. 2020 Aug 12;20(1):208. doi: 10.1186/s12874-020-01089-6.
IDegLira 对比二甲双胍和基础胰岛素治疗控制不佳的 2 型糖尿病患者的疗效和安全性:DUAL VII 随机临床试验。
Diabetes Care. 2018 May;41(5):1009-1016. doi: 10.2337/dc17-1114. Epub 2018 Feb 26.
4
Controlled pattern imputation for sensitivity analysis of longitudinal binary and ordinal outcomes with nonignorable dropout.有非随机缺失时纵向二分类和有序结局敏感性分析的受控模式插补。
Stat Med. 2018 Apr 30;37(9):1467-1481. doi: 10.1002/sim.7583. Epub 2018 Jan 15.
5
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.茚达品作为胆碱酯酶抑制剂辅助药物对阿尔茨海默病患者认知功能变化的影响:三项随机临床试验
JAMA. 2018 Jan 9;319(2):130-142. doi: 10.1001/jama.2017.20373.
6
Control-based imputation for sensitivity analyses in informative censoring for recurrent event data.用于复发事件数据信息删失中敏感性分析的基于对照的插补法。
Pharm Stat. 2017 Nov;16(6):424-432. doi: 10.1002/pst.1821. Epub 2017 Aug 22.
7
Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.针对存在健康结局缺失情况的随机对照试验,开发一种实用的专家意见征集方法:在IMPROVE试验中的应用。
Clin Trials. 2017 Aug;14(4):357-367. doi: 10.1177/1740774517711442. Epub 2017 Jul 4.
8
Choosing estimands in clinical trials with missing data.在存在缺失数据的临床试验中选择估计量。
Pharm Stat. 2017 Jan;16(1):29-36. doi: 10.1002/pst.1765. Epub 2016 Aug 5.
9
Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints.在事件发生时间终点分析中对随机删失假设的敏感性。
Pharm Stat. 2016 May;15(3):216-29. doi: 10.1002/pst.1738. Epub 2016 Mar 21.
10
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.在没有随机试验时使用大数据模拟目标试验。
Am J Epidemiol. 2016 Apr 15;183(8):758-64. doi: 10.1093/aje/kwv254. Epub 2016 Mar 18.